NF-κB, an Active Player in Human Cancers

Sen, 1986, Multiple nuclear factors interact with the immunoglobulin enhancer sequences, Cell, 46, 705, 10.1016/0092-8674(86)90346-6

Liu, 2012, IKK biology, Immunol Rev, 246, 239, 10.1111/j.1600-065X.2012.01107.x

Li, 2002, NF-kappaB regulation in the immune system, Nat Rev Immunol, 2, 725, 10.1038/nri910

Gilmore, 1999, Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel, Oncogene, 18, 6925, 10.1038/sj.onc.1203222

Gilmore, 2004, The c-Rel transcription factor and B-cell proliferation: a deal with the devil, Oncogene, 23, 2275, 10.1038/sj.onc.1207410

Neri, 1991, B cell lymphoma–associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50, Cell, 67, 1075, 10.1016/0092-8674(91)90285-7

Bredel, 2011, NFKBIA deletion in glioblastomas, N Engl J Med, 364, 627, 10.1056/NEJMoa1006312

Greenman, 2007, Patterns of somatic mutation in human cancer genomes, Nature, 446, 153, 10.1038/nature05610

Pflueger, 2011, Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing, Genome Res, 21, 56, 10.1101/gr.110684.110

Boehm, 2007, Integrative genomic approaches identify IKBKE as a breast cancer oncogene, Cell, 129, 1065, 10.1016/j.cell.2007.03.052

Serhan, 2008, Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators, Nat Rev Immunol, 8, 349, 10.1038/nri2294

Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Terzic, 2010, Inflammation and colon cancer, Gastroenterology, 138, 2101, 10.1053/j.gastro.2010.01.058

Iliopoulos, 2009, An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation, Cell, 139, 693, 10.1016/j.cell.2009.10.014

Pikarsky, 2004, NF-kappaB functions as a tumour promoter in inflammation-associated cancer, Nature, 431, 461, 10.1038/nature02924

Gabrilovich, 2009, Myeloid-derived suppressor cells as regulators of the immune system, Nat Rev Immunol, 9, 162, 10.1038/nri2506

Long, 2009, Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor, Immunity, 31, 921, 10.1016/j.immuni.2009.09.022

Facciabene, 2012, T-regulatory cells: key players in tumor immune escape and angiogenesis, Cancer Res, 72, 2162, 10.1158/0008-5472.CAN-11-3687

Hagemann, 2008, “Re-educating” tumor-associated macrophages by targeting NF-kappaB, J Exp Med, 205, 1261, 10.1084/jem.20080108

Porta, 2009, Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB, Proc Natl Acad Sci U S A, 106, 14978, 10.1073/pnas.0809784106

Colotta, 2009, Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability, Carcinogenesis, 30, 1073, 10.1093/carcin/bgp127

Elinav, 2013, Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms, Nat Rev Cancer, 13, 759, 10.1038/nrc3611

Matsumoto, 2007, Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium, Nat Med, 13, 470, 10.1038/nm1566

Gerondakis, 2006, Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models, Oncogene, 25, 6781, 10.1038/sj.onc.1209944

Meylan, 2009, Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma, Nature, 462, 104, 10.1038/nature08462

Xia, 2012, Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model, Nat Cell Biol, 14, 257, 10.1038/ncb2428

Basseres, 2010, Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis, Cancer Res, 70, 3537, 10.1158/0008-5472.CAN-09-4290

Forsythe, 1996, Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1, Mol Cell Biol, 16, 4604, 10.1128/MCB.16.9.4604

Huang, 2001, Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis, Oncogene, 20, 4188, 10.1038/sj.onc.1204535

John, 2001, The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis, Pathol Oncol Res, 7, 14, 10.1007/BF03032599

Kang, 2004, Epithelial-mesenchymal transitions: twist in development and metastasis, Cell, 118, 277, 10.1016/j.cell.2004.07.011

Li, 2012, Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB–mediated transcriptional upregulation of Twist1, Cancer Res, 72, 1290, 10.1158/0008-5472.CAN-11-3123

Wu, 2009, Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion, Cancer Cell, 15, 416, 10.1016/j.ccr.2009.03.016

Collins, 1995, Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers, FASEB J, 9, 899, 10.1096/fasebj.9.10.7542214

Nguyen, 2009, Metastasis: from dissemination to organ-specific colonization, Nat Rev Cancer, 9, 274, 10.1038/nrc2622

Hiratsuka, 2006, Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis, Nat Cell Biol, 8, 1369, 10.1038/ncb1507

Kawauchi, 2008, p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation, Nat Cell Biol, 10, 611, 10.1038/ncb1724

Kawauchi, 2009, Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification, Proc Natl Acad Sci U S A, 106, 3431, 10.1073/pnas.0813210106

Mauro, 2011, NF-kappaB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration, Nat Cell Biol, 13, 1272, 10.1038/ncb2324

Barbie, 2009, Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1, Nature, 462, 108, 10.1038/nature08460

Chien, 2006, RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival, Cell, 127, 157, 10.1016/j.cell.2006.08.034

Bang, 2013, GSK-3alpha promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-kappaB, Cancer Discov, 3, 690, 10.1158/2159-8290.CD-12-0541

Singh, 2012, TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers, Cell, 148, 639, 10.1016/j.cell.2011.12.033

Duran, 2008, The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis, Cancer Cell, 13, 343, 10.1016/j.ccr.2008.02.001

Ling, 2012, KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma., Cancer Cell, 21, 105, 10.1016/j.ccr.2011.12.006

Webster, 1999, Transcriptional cross talk between NF-kappaB and p53, Mol Cell Biol, 19, 3485, 10.1128/MCB.19.5.3485

Huang, 2007, Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB, Mol Cell, 26, 75, 10.1016/j.molcel.2007.02.019

Martin, 2005, Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3, Nat Immunol, 6, 777, 10.1038/ni1221

Giebler, 2000, p53 recruitment of CREB binding protein mediated through phosphorylated CREB: a novel pathway of tumor suppressor regulation, Mol Cell Biol, 20, 4849, 10.1128/MCB.20.13.4849-4858.2000

Xia, 2009, Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP, Proc Natl Acad Sci U S A, 106, 2629, 10.1073/pnas.0812256106

Tergaonkar, 2002, p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy, Cancer Cell, 1, 493, 10.1016/S1535-6108(02)00068-5

Cooks, 2013, Mutant p53 prolongs NF-kappaB activation and promotes chronic inflammation and inflammation-associated colorectal cancer, Cancer Cell, 23, 634, 10.1016/j.ccr.2013.03.022

Greten, 2004, IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer, Cell, 118, 285, 10.1016/j.cell.2004.07.013

Maeda, 2005, IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis, Cell, 121, 977, 10.1016/j.cell.2005.04.014

Luedde, 2007, Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma, Cancer Cell, 11, 119, 10.1016/j.ccr.2006.12.016

Dajee, 2003, NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia, Nature, 421, 639, 10.1038/nature01283

van Hogerlinden, 1999, Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling, Cancer Res, 59, 3299

Pham, 2004, Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species, Cell, 119, 529, 10.1016/j.cell.2004.10.017

Kamata, 2005, Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases, Cell, 120, 649, 10.1016/j.cell.2004.12.041

Keutgens, 2006, Deregulated NF-kappaB activity in haematological malignancies, Biochem Pharmacol, 72, 1069, 10.1016/j.bcp.2006.06.011

Greten, 2007, NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta, Cell, 130, 918, 10.1016/j.cell.2007.07.009

Xue, 2011, Response and resistance to NF-kappaB inhibitors in mouse models of lung adenocarcinoma, Cancer Discov, 1, 236, 10.1158/2159-8290.CD-11-0073

Wu, 2006, Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli, Science, 311, 1141, 10.1126/science.1121513

Wang, 1999, Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB, Nat Med, 5, 412, 10.1038/7410

Cusack, 2001, Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition, Cancer Res, 61, 3535

Bhat, 2013, Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma, Cancer Cell, 24, 331, 10.1016/j.ccr.2013.08.001

Takahashi, 2010, Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation, Cancer Cell, 17, 89, 10.1016/j.ccr.2009.12.008